TIDMRTW

RNS Number : 5644O

RTW Biotech Opportunities Ltd

03 October 2023

LEI: 549300Q7EXQQH6KF7Z84

03 October 2023

RTW Biotech Opportunities Ltd

(the "Company")

Director Declaration

In accordance with Listing Rule 9.6.14(2), the Company advises that Paul Le Page, a non-executive director of the Company, has been appointed as an independent non-executive director of NextEnergy Solar Fund Limited, a LSE listed FTSE 250 company, with effect from 03 October 2023. In addition, Paul Le Page has recently resigned from Bluefield Solar Investment Fund Limited, an LSE listed FTSE 250 company.

Paul's role at NextEnergy Solar Fund Limited is not expected to impact his ability to allocate sufficient time to the Company to discharge his responsibilities effectively.

For Further Information:

 
 RTW Investments, LP                                  +44 20 7959 6361 
 Woody Stileman, Managing Director 
  Krisha McCune, Director, Client Service 
 
 Buchanan                                             +44 20 7466 5107 
 Charles Ryland 
 Henry Wilson 
 George Beale 
 
 Numis                                                +44 20 7260 1000 
 Freddie Barnfield 
 Nathan Brown 
 Euan Brown 
 
 BofA Securities                                      +44 20 7628 1000 
 Edward Peel 
 Kieran Millar 
 
 Cadarn Capital                                       +44 73 6888 3211 
 David Harris 
 
 Elysium Fund Management Limited 
  Joanna Duquemin Nicolle, Chief Executive Officer 
  Sadie Morrison, Managing Director                   +44 (0) 14 8181 0100 
 
 Morgan Stanley Fund Services USA LLC                 +1 914 225 8885

About RTW Biotech Opportunities Ltd:

RTW Biotech Opportunities Ltd (LSE: RTW & RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities Ltd invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives. RTW Biotech Opportunities Ltd is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

   Visit the website at  www.rtwfunds.com/rtw-biotech-opportunities-ltd   for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNBXBDGGSGDGXX

(END) Dow Jones Newswires

October 03, 2023 11:00 ET (15:00 GMT)

Rtw Biotech Opportunities (LSE:RTWG)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Rtw Biotech Opportunities.
Rtw Biotech Opportunities (LSE:RTWG)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Rtw Biotech Opportunities.